Penyebab intoksisasi ada banyak macam, yang sering terjadi adalah karena kecelakaan atau, disengaja / bunuh diri. Di Amerika intoksikasi ± 75% terjadi pada anak umumnya karena keracunan produk rumah tangga
A. Agen Intoksikasi
Terjadi pada semua umur remaja: obat-obat psikotropik, sedative, transqualizer, antidepresan dan obat-obat narkotik. dewasa umumnya karena kecelakaan kerja (karbon monoksida, pestisida, keracunan makanan, dll)
Mekanisme cidera masing-masing racun memiliki efek patologis yang berbeda-beda dimana masing masing racun memiliki patologi sendiri-sendiri. Efek racun dapat terjadi pada tempat atau sekitar masuknya racun (misalnya reaksi kimia sitotoksin) dan dapat berupa toksisitas sistemik yaitu efek-efek selektif racun atau efek metabolik khusus dari racun itu terhadap target yang spesifik misalkan asetaminofen di liver, methanol diretina, dll.
C. Pengkajian Prioritas Utama
1. Pengkajia riwayat kejadian, tanyakan pada pengantar pasien/pasien sendiri jika kooperatif.
2. Pengjakian fisik : Initial assessment/ Arway- Breathing- Cirkulating ( ABC)
a. Tingkat kesadaran
b. Pernafasan dan efektifitas nafas
c. Irama jantung
d. Ada tidaknya kejang
e. Keadaan dan warna kulit
f. Besar dan reaksi pupil mata
g. lesi, bau mulut, dan lainnya
Terkadang setelah mendapatkan resusitasi (ABC) sering dilanjutkan dengan perawatan suportif di ICU dan dilakukan pengeluaran zat penyebab dari tubuh serta mungkin diperlukan antidotumnya.
Jika didapat pasien tidak sadar dengan penyebab yang Belum jelas, perlu selalu difikirkan adanya kemungkinan intoksikasi. tindakan pertama:menjaga jalan nafas, oksigen ( biasanya tidak kurang dari 6 lt / menit), K/p bantuan nafas, IV line, kemudian cek seluruh tubuh adanya tanda-tanda kemungkinan mendapat obat atau racun, periksa adanya bekas suntikan, zat terminum bau nafas dan lainnya dan perkirakan juga kemungkinan terjadinya hipoglikemi.
D. Evaluasi/outcome umum pd intoksikasi
Stabilisasi & menigkatnya kardiorespirasi, kriteria :
sistolik 100mmHg, nadi 60 – 100X / menit, irama reguler
respirasi 24 X/ menit, tidak ada rales, tidak ada wheezing
1. Carbon Monoxide Poisoning
Carbon monoxide (CO), is a colorless, odorless, toxic gas that is a product of incomplete combustion. Motor vehicles, heaters, appliances that use carbon based fuels, and household fires are the main sources of this poison.
2. Carbon monoxide (CO)
Carbon monoxide (CO) intoxication is the leading cause of death due to poisoning in the United States and also the most common cause of death in combustion related inhalation injury. The incidence of non-lethal CO poisoning is not well established nor is that of unrecognized CO poisonin. Mortality rates as high as 31% have been reported in large series
Most immediate deaths from building fires are due to CO poisoning and therefore, fire fighters are at high risk.
a. Exogenous Sources of CO
b. Car exhaust fumes
d. Gas-powered engines
e. Home water heaters
f. Paint removers containing methylene chloride
g. Pool heaters
h. Smoke from all types of fire
i. Sterno fuel
j. Tobacco smoke
k. Wood stoves
In patients who die early following CO poisoning the brain is edematous, and there are diffuse petechia and hemorrhages. If the victim survives initially but dies within a few weeks, findings typical of ischemic anoxia are prominent. Interestingly, the severity of the lesions appears to correlate best with the degree of hypotension rather than with hypoxia.
1. Hypoxia and cellular asphyxia
CO combines preferentially with hemoglobin to produce COHb, displacing oxygen and reducing systemic arterial oxygen (O2) content. CO binds reversibly to hemoglobin with an affinity 200- 230 times that of oxygen. Consequently, relatively minute concentrations of the gas in the environment can result in toxic concentrations in human blood. Possible mechanisms of toxicity include: decrease in the oxygen carrying capacity of blood. Alteration of the dissociation characteristics of oxyhemoglobin, further decreasing oxygen delivery to the tissues. Decrease in cellular respiration by binding with cytochrome a3. Binding to myoglobin, potentially causing myocardial and skeletal muscle dysfunction.
In addition to causing tissue hypoxia, CO can cause injury by impairing tissue perfusion, indicate that myocardial depression, peripheral vasodilation, and ventricular arrhythmia causing hypotension may be important in the genesis of neurologic injury.
3. Reperfusion injury
Many of the pathophysiologic changes are similar to those seen with postischemic reperfusion injuries, and similar pathology occurs in the brain in the absence of CO when hypoxic hypoxia precedes an interval of ischemia.
Many victims of CO poisoning die or suffer permanent, severe neurological injury despite treatment. In addition, as many as 50% of those who recover consciousness and survive may experience varying degree of more subtle but still disabling neuropsychiatric sequela.
The features of acute CO poisoning are more dramatic than those resulting from chronic exposure. The clinical presentation of acute CO poisoning is variable, but in general, the severity of observed symptoms correlates roughly with the observed level of COHb:
COHb Levels and Symptomatology
a. 10% Asymptomatic or may have headaches
b. 20% Dizzyness, nausea, and syncope
c. 30% Visual disturbances
d. 40% Confusion and syncope
e. 50% Seizures and coma
f. 60% Cardiopulmonary dysfunction & death
The mainstay of therapy for CO poisoning is supplemental O2, ventilatory support and monitoring for cardiac arrhythmias. There is general agreement that 100% oxygen should be administered prior to laboratory confirmation when CO poisoning is suspected. The goal of oxygen therapy is to improve the O2 content of the blood by maximizing the fraction dissolved in plasma (PaO2).36 Once treatment begins, O2 therapy and observation must continue long enough to prevent delayed sequelae as carboxymyoglobin unloads.
The most controversial and widely debated topic regarding CO poisoning is the use of hyperbaric oxygen (HBO). The most controversial and widely debated topic regarding CO poisoning is the use of hyperbaric oxygen (HBO) severe poisoning should be treated with 100% oxygen, with endotracheal intubation in patients who cannot protect their airway. In these patients, consideration should be given to transfusion of packed red blood cells.
30% of patients with severe poisoning have a fatal outcome.49 One study has estimated that 11% of survivors have long-term neuropsychiatric deficits, including 3% whose neurologic manifestations are delayed. One third of CO poisoning victims may have subtle but lasting memory deficits or personality changes.40. Indicators of a poor prognosis include altered consciousness at presentation, advanced age, patients with underlying cardiovascular disease, metabolic acidosis, and structural abnormalities on CT or MRI scanning.
Organophosphate and Carbamate Poisioning
Although OPC and carbamates are structurally distinct, they have similar clinical manifestations and generally the same management. Although most patients with OPC and carbamate poisoning have a good prognosis, severe poisoning is potentially lethal. Early diagnosis and initiation of treatment are important. The ED physician has access to a number of therapeutic options that can decrease morbidity and mortality.
OPCs and carbamates bind to 1 of the active sites of acetylcholinesterase (AChE) and inhibit the functionality of this enzyme by means of steric inhibition. The main purpose of AChE is to hydrolyze acetylcholine (ACh) to choline and acetic acid. Therefore, the inhibition of AChE causes an excess of ACh in synapses and neuromuscular junctions, resulting in muscarinic and nicotinic symptoms and signs.
Excess ACh in the synapse can lead to 3 sets of symptoms and signs. First, accumulation of ACh at postganglionic muscarinic synapses lead to parasympathetic activity of smooth muscle in lungs, the GI tract, heart, eyes, bladder, and secretory glands, and increased activity in postganglionic sympathetic receptors for sweat glands. This results in the symptoms and signs that can be remembered with the mnemonic SLUDGE/BBB. Second, excessive ACh at nicotinic motor end plates causes persistent depolarization of skeletal muscle (analogous to that of succinylcholine), resulting in fasciculations, progressive weakness, and hypotonicity. Third, as OPs cross the blood-brain barrier, they may cause seizures, respiratory depression, and CNS depression for reasons not completely understood.
J. Signs & Symptoms
Patients often present with evidence of a cholinergic toxic syndrome, or toxidrome. SLUDGE/BBB mnemonic :
S = Salivation
L = Lacrimation
U = Urination
D = Defecation
G = GI symptoms
E = Emesis
B = Bronchorrhea
B = Bronchospasm
B = Bradycardia
D = Diarrhea and diaphoresis
U = Urination
M = Miosis
B = Bronchorrhea, bronchospasm, and bradycardia
E = Emesis
L = Lacrimation
S = Salivation
K. Lab & Test
Serum cholinesterase and RBC AChE activity, which are used to estimate neuronal AChE activity. Other Tests: ECG, prolonged QTc interval is the most common ECG abnormality. Elevation of the ST segment, sinus tachycardia, sinus bradycardia, and complete heart block (rare) may also occur. (Sinus tachycardia occurs just as commonly as sinus bradycardia.)
L. Prehospital Care
Identification of the type of chemical is important. As a general rule, dimethyl OPCs undergo rapid aging, which makes early initiation of oximes critical. In comparison, diethyl compounds may cause delayed toxicity, and oxime therapy may need to be prolonged.
M. Emergency Department Care
Care of the ABCs should be initiated first because intubation may be necessary in cases of severe poisoning. Because succinylcholine is metabolized by means of plasma cholinesterase, OPC or carbamate poisoning may cause prolonged paralysis. Increased doses of nondepolarizing agents, such as pancuronium or vecuronium, may be required to achieve paralysis because of the excess ACh at the receptor.
Providers with appropriate personal protective equipment (PPE) can address the ABCs before decontamination atropine can precipitate ventricular fibrillation in hypoxic patients. Paradoxically, the early use of adequate atropine will dry respiratory secretions, improve muscle weakness and thereby improve oxygenation. The following should be monitored on a regular basis to assess the patient's respiratory status:
a. Respiratory rate
b. Tidal volume/ vital capacity
c. Neck muscle weakness
d. Ocular muscle involvement eg. diplopia
e. Arterial blood gas analysis
f. Cardiac monitoring, a wide range of cardiac manifestations can occur and careful haemodynamic and electrocardiac monitoring hypoxaemia, metabolic and electrolyte abnormalities can all contribute to cardiac arrhythmias. Some arrhythmias may require cardiac pacing.
Important part of the initial care, decontamination depends on the route of poisoning. The patient's body should then be thoroughly washed with soap and water to prevent further absorption from the skin. Washing the poisioned person and removing contaminated clothes nosocomial poisoning in staff members treating patients who have been exposed to OPCs and carbamates; the odors often smelled when one cares for a patient poisoned from pesticide are commonly due to the hydrocarbon solvent, which may cause symptoms independent of the OPC agent. The patient's clothes must be removed and isolated, and his or her body washed with soap and water.GI decontamination: Oral administration of activated charcoal is a reasonable intervention after GI poisoning. Gastric emptying should then be considered if the patient presents within 1 hour of ingestion. Gastric lavage is the only means of emptying the stomach in unconscious patients in which case the airway needs to be protected.
Atropine is a pure muscarinic antagonist that competes with ACh at the muscarinic receptor.
most commonly given in intravenous (IV) form at the recommended dose of 2-5 mg for adults and 0.05 mg/kg for kids with a minimum dose of 0.1 mg to prevent reflex bradycardia. Atropine may be redosed every 5-10 minutes. Severe OP poisonings often require hundreds of milligrams of atropine. In 1 case report, a patient required frequent doses of atropine and was eventually converted to an atropine infusion to a total of 30 g over 5 days.
Most sources recommend starting atropine on patients with anything more than ocular effects and then observing the drying of secretions as an endpoint in titrating to the appropriate dose. From the Tokyo sarin experience, patients poisoned by nerve agents had modest atropine requirements, with none requiring more than 10 mg. The recommended starting dose of atropine is a 2mg IV bolus. Subsequent doses of 2-5mg every 5-15 minutes should be administered until atropinization is achieved. The signs of adequate atropinization include an increased heart rate (>100 beats/min.), moderately dilated pupils, a reduction in bowel sounds, a dry mouth and a decrease in bronchial secretions.
Seizures are an uncommon complication of OP poisoning. When they occur, they represent severe toxicity.
5. Other treatments
magnesium and fresh-frozen plasma as adjunctive therapy. both must be evaluated. Nebulized ipratropium bromide as an adjunct agent.
N. Management of Organophosphorus compunds poisoning
1. Skin decontamination **
2. Airway protection if indicated **
3. Gastric lavage
4. Activated charcoal 0.5-1gm/kg every 4hr
5. Anticholinesterase: Atropine/glycopyrrolate **
6. Cholinesterase reactivator: Pralidoxine
7. Ventilatory support
8. Inotropic support
9. Benzodazepines ( if seizure) **
** = useful
O. Further Inpatient Care
Patients who require continuous monitoring or treatment should be admitted to the ICU. Patients with clinically significant poisoning should be evaluated frequently to monitor their airway and respiratory secretions. In addition, frequent neurologic examination should be performed to evaluate for neuromuscular blockade. Therapy is largely titrated to the physical findings. Atropinization is based on the drying of respiratory secretions, and oxime therapy is based on an improvement in neuromuscular signs. A toxicologist may be of help in determining specific aging and reactivation times of the particular OPC or carbamate agent.
P. Further Outpatient Care:
Patients without any symptoms and with questionable or minimal exposure to OPs or carbamates may be considered for discharge after 6-12 hours of observation. Patients with residual neurologic symptoms should be given a follow-up appointment with a neurologist. Follow-up with a psychiatrist should be arranged as indicated.
1. Intermediate syndrome, Intermediate syndrome was first described in 1987 as a sudden respiratory paresis, with weakness in cranial nerves and proximal-limb and neck flexor muscles. These clinical features appear 24-96 hours after exposure and are distinct from the previously described delayed neurotoxicity (see below). Although intermediate syndrome is incompletely understood, more recent reports suggest this is due to presynaptic and postsynaptic dysfunction of neuromuscular transmission and that it may result from insufficient oxime treatment.
2. OPC-induced delayed neurotoxicity (OPCIDN), OPCIDN is a sensorimotor polyneuropathy that typically occurs 9-14 days after OP exposure. The patient initially presents with distal motor weakness and sensory paresthesias in the lower extremities, which may progress proximally and eventually affect the upper extremities. Most sources suggest the mechanism involves inhibition of neuropathy target esterase (NTE), an enzyme that metabolizes esters in nerve cells. Some patients may recover over 12-15 months, but permanent losses with spasticity and persistent upper motor neuron findings have been reported.
3. Pancreatitis, Pancreatitis has been reported as a rare complication. One case series reported that 12.76% of OP poisonings were associated with acute pancreatitis, though this has not been the experience in other series.
In severe poisoning, death usually occurs within the first 24 hours if it is untreated. With nerve-agent poisoning, death may occur within minutes if untreated. Even with adequate respiratory support, intensive care, and specific treatment with atropine and oximes, the mortality rate is still high in severe poisonings. A delay in treatment can also lead to late and permanent neurologic sequelae. Most patients with minimal symptoms fully recover.
S. Special Concerns
Pregnant women should receive the same treatment as that given to other adults. Both atropine and pralidoxime are class C drugs in pregnancy. In the Tokyo subway attacks, 5 pregnant women were mildly poisoned, and all had normal babies without complications.